Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 13 November 2025

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1675265

Correction: A current review on animal models of anti-asthmatic drugs screening

Shivam Singh
Shivam Singh1*Sunita KulariaSunita Kularia1Shivakshi ShuklaShivakshi Shukla1Mithilesh SinghMithilesh Singh2Manish KumarManish Kumar1Ashish Kumar SharmaAshish Kumar Sharma1
  • 1Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, Rajasthan, India
  • 2Department of Pharmaceutical Chemistry, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India

A Correction on
A current review on animal models of anti-asthmatic drugs screening

by Singh S, Kularia S, Shukla S, Singh M, Kumar M and Sharma AK (2025). Front. Pharmacol. 16:1508460. doi: 10.3389/fphar.2025.1508460

In the Abstract, the phrase “In-vitro Animal Models” was erroneously used in place of “In-vitro Models”.

A correction has been made to the Abstract:

“Both genetic and traditional models of anti-asthmatic agents, their characteristics, and their significance are summarized as: In-vitro Models: Histamine receptor assay, Cell Culture Method, WST Assay, Spasmolytic Activity of the Lungs of Guinea Pigs, Airway and Vascular Responses to an Isolated Lung, The Isolated Perfused Guinea Pig Trachea’s Reactivity.”

In the Introduction, subheading 2.1 was incorrectly called “In vitro animal models” in place of “In vitro models.”

Subheading 2.1 has now been corrected as “2.1 In vitro models” in section Introduction, 2 Anti-Asthmatic drug screening models, 2.1 In vitro models.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: leukotrienes, hyperresponsiveness, inflammation, anaphylactic, microshock

Citation: Singh S, Kularia S, Shukla S, Singh M, Kumar M and Sharma AK (2025) Correction: A current review on animal models of anti-asthmatic drugs screening. Front. Pharmacol. 16:1675265. doi: 10.3389/fphar.2025.1675265

Received: 29 July 2025; Accepted: 05 November 2025;
Published: 13 November 2025.

Edited and reviewed by:

John M. Seubert, University of Alberta, Canada

Copyright © 2025 Singh, Kularia, Shukla, Singh, Kumar and Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shivam Singh, c3M2NDA0MjEzQGdtYWlsLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.